Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 379-383, February 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, T.
Right arrow Articles by Nitta, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, T.
Right arrow Articles by Nitta, K.

Dependence on Chain Length of Antitumor Activity of (1 -> 3)-ß-D-Glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and Its Acid-degraded Products1

Takuma Sasaki2, Noriko Abiko, Yukio Sugino3 and Kazuo Nitta

Chemotherapy Division, National Cancer Center Research Institute, Tsukiji 5-chome, Chuo-ku, Tokyo, Japan 104

The well-defined (1 -> 3)-ß-D-glucan with Formula 540, produced by cultivation of Alcaligenes faecalis var. myxogenes (IFO 13140), a mutant of a soil bacterium, had marked inhibitory activity against the s.c.-implanted Sarcoma 180 at 5 to 50 mg/kg for 10 days. It also exhibited very high activity in doses of 60 and 100 mg/kg i.p. by a single injection at 7 days after the initial s.c. transplantation of Sarcoma 180. The inhibition ratios observed with Ehrlich carcinoma, NTF (Nakahara-Tokuzen-Fukuoka) reticulum cell sarcoma, and CCM adenocarcinoma were somewhat less but were still significant. On the other hand the treatment failed to inhibit the growth of ascites Sarcoma 180 or to induce prolongation of life span. The mechanism of action of this glucan was considered to be host mediated because of a lack of effect in vitro and also because of the effectiveness of pretreatment of animals by injection before transplantation of a tumor. The results from the bioassay study of the lower-molecular-weight (1 -> 3)-ß-D-glucans prepared from the glucan with number-average degrees of polymerization Formula 540 by hydrolysis with formic acid or sulfuric acid showed that the glucans with Formula inhibited the growth of Sarcoma 180 implanted s.c. in mice, whereas the result of the schedule-dependent effect was obtained in the pretreatment of animals by the glucan with Formula 50. By i.v. administration, even the glucan with Formula 16 showed a strong antitumor effect comparable to that of the glucan with Formula 540.

1 This work was supported in part by Grants-in-Aid for Cancer Research from both the Ministry of Health and Welfare and the Ministry of Education, Science and Culture, Japan.

2 To whom requests for reprints should be addressed, at Section of Experimental Chemotherapy, Division of Chemotherapy, National Cancer Center Research Institute, Tsukiji 5-chome, Chuo-ku, Tokyo, Japan 104.

3 Permanent address: Central Research Division, Takeda Chemical Industries, Ltd., Osaka, Japan.

Received 7/ 8/77. Accepted 11/11/77.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Kataoka, T. Muta, S. Yamazaki, and K. Takeshige
Activation of Macrophages by Linear (1right-arrow3)-beta -D-Glucans. IMPLICATIONS FOR THE RECOGNITION OF FUNGI BY INNATE IMMUNITY
J. Biol. Chem., September 20, 2002; 277(39): 36825 - 36831.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.